About
I've had the good fortune to lead the creation and rapid growth of 3 companies, each of…
Articles by Michael
Activity
5K followers
-
Michael Baker shared thisIt's exciting to see the progress that entrepreneurs like Phuong Jean Pham and companies Cellens Inc are making in using AI for critical things like cancer detection. When AI can reduce human suffering it will have fulfilled its potential for good.Michael Baker shared thisClosing out an unforgettable 2025, I’m incredibly proud to share that Cellens Inc has raised $6.5M to advance our AI-driven mechanobiology platform for non-invasive bladder cancer diagnostics. This milestone is grounded in early clinical data showing our urine-based test detected 100% of recurrence cases, with an AUC of 88%—highlighting what’s possible when we look beyond molecular markers and instead measure the physics of cancer. Bladder cancer patients today endure repeated invasive cystoscopies, the majority of which are negative. We believe accurate, non-invasive surveillance can meaningfully improve the patient quality-of-care while reducing invasive procedures and healthcare costs. I’ll be candid: raising an early-stage cancer diagnostics company in this market takes the whole village. Capital is cautious and timelines are long, especially when you’re building something that is truly differentiated. But it is doable! I’m deeply grateful to our lead investor SOSV, along with Labcorp Venture Fund, Blackwood Healthcare Breakthroughs, Kolon Industries, Inc, Tufts University, BrightEdge - American Cancer Society, CANCER FUND Impact Investments™, and TiE Boston Angels, as well as strategic R&D partner Bruker, for believing in our mission. Honored to work with a dream Board Mohan Iyer, Deborah Zajac, Jesse Salk and Lena Chaihorsky whose perspective and conviction helped us navigate both the science and the fundraising in a challenging market. Most importantly, thank you to the clinicians and patients who made this work possible. This is just the beginning! Please reach out if you'd like to collaborate! As we head into the holidays, I’m filled with gratitude—and excitement for what’s ahead. I’ll be at JPM 2026 and am currently booking meetings—would love to connect in the new year. Thank you Jared Whitlock and Endpoints News for taking the time to cover this milestone. 📰 Read the exclusive here: https://lnkd.in/ea8q7T3x 📰 Read the company's press release here: https://lnkd.in/eHhdDaNcExclusive: Cellens raises $6.5M to advance physics-based test for bladder cancerExclusive: Cellens raises $6.5M to advance physics-based test for bladder cancer
-
Michael Baker shared thisI think what TAPPP is doing with on-TV screen, in-game sports betting is one of the most innovative things happening in the world of TV and Sports. Lots of interesting possibilities for brands too. https://lnkd.in/eb6pGMCjMichael Baker shared this🏆 What an incredible honor! Last night at the SBC Summit Americas, TAPPP was named The Rising Star in Sports Betting at the SBC Awards. This recognition is a true testament to the relentless hard work, innovation, and passion of our amazing team — and the unwavering support of our incredible partners. Thank you all for being part of this journey. Onward and upward! #SBCawards #SBCSummitAmericas #SportsBetting #Innovation #RisingStar
-
Michael Baker shared thisExciting milestone for AgelessRX! When I first met Anar Isman and his team 4 years ago I was impressed with their ambitious mission to slow age-related decline. Today they've become a leader in the burgeoning longevity space, and they've done it by building a trusted brand.Michael Baker shared thisWe’re honored to be named an XPRIZE Healthspan finalist. This is bigger than a badge—it’s a signal that the longevity movement is reaching a tipping point. Our healthcare system is broken and it treats aging as inevitable and does not see anything wrong with it. There’s no label for “aging,” which means there’s no financial incentive for big pharma to invest in drugs that could slow it down, because without a label, interventions are off-label—and insurance won’t touch them. XPRIZE is changing that. By creating a prize structure that rewards progress on aging itself, it’s unlocking new incentives for biotech companies to develop interventions that could slow - or even reverse - aging. We’ve been preparing for this moment since day one. Our company is built by mission-driven longevity specialists, and longevity is in our DNA– from our Applied Science team and our Rapamycin clinical trial to the infrastructure and partnerships we’ve built to run decentralized clinical trials and generate insights that move the field forward. So it's very exciting that our team at AgelessRx just advanced to the semi-finals of the $101M XPRIZE Healthspan competition, one of 40 global teams tackling the biggest human atrocity: age-related decline. The grand prize goes to the team that can reverse age-related decline across muscle, immune, and cognitive function in just 1 year. Our approach is a unique clinical protocol that: → Combines effective, repurposed FDA-approved treatments → Targets root causes across systems → Includes advanced aging biomarkers, digital monitoring and expert licensed clinical oversight I truly think longevity is a movement, not an industry or a sector. It’s exciting to be a part of the first domino in the Longevity Revolution, but this is just the beginning. If you are interested in ways to advance the movement and keep pushing the boundaries of what’s possible for human healthspan - lets talk. #XPRIZEHealthspan #XPRIZE 🔗 https://lnkd.in/g5pD-RPiAgelessRx Named Semi-Finalist in $101M XPRIZE Healthspan Global CompetitionAgelessRx Named Semi-Finalist in $101M XPRIZE Healthspan Global Competition
-
Michael Baker shared thisI’m a moderate and not political but if Trump was a CEO he’d be fired already for tanking USA consumer confidence and markets, which are literally freezing up given daily “let’s see what happens” ego-fed tweets. I’ve had 3 conversations this week with institutional investors who are telling me the many sectors they are now NOT investing in. Killing jobs, 401Ks, and here comes the Trump inflation to undermine everyone’s earning power
-
Michael Baker shared thisI'm a user of Flat too. It's simple and powerful unlike sooo many legacy project management tools. And it's free for smaller teams. I like it so much i invested in the company 😁Michael Baker shared thisThis year, I’ve had the opportunity to step into a new role where I’m overseeing projects involving a variety of teams, facilities, and vendors. Staying organized and keeping everything on track has been a challenge, and I’ve tried several different project tracking tools to help streamline the process. After testing a variety of solutions, none have been as intuitive and user-friendly as Flat. If you’re looking for a solution that keeps things organized without adding complexity, I highly recommend giving it a try. https://flat.app/
-
Michael Baker shared thisAI is starting to make CTV ads a lot better for viewers and brands. Great to see iris.tv scaling up to meet the demand!Michael Baker shared thisWe’re excited to announce the launch of our contextual CTV deal library, where advertisers activate curated video-level contextual private marketplaces for IAB context, GARM Brand Safety, Emotional Resonance, Audience Lookalikes, Seasonal deals and more. Select from a variety of PMPs and target millions of viewers watching relevant and brand-suitable shows and movies across thousands of premium apps and FAST channels. Click here to learn more and explore our library > https://bit.ly/3uQhIhT #connectedtv #programmatic #adtech #ctv #ai #iristv
-
Michael Baker shared thisProgrammatic approach to B2B marketing … some much need innovation in the B2B leads space! Congratulations Karl and Roland on GA of your exchangeMichael Baker shared thisBuilding a business is hard work. Long hours, few resources, and confronted with a thousand naysayers and doubters. Proud of my team at Audyence for pushing through those obstacles and more. Feels good to see the market taking notice of what YOU built. If you missed the below...we're officially out of beta and taking the B2B account-based-marketing and lead generation industry by storm 🌪 The word is out and B2B demand marketing will never be the same 😉 VentureBeat: https://lnkd.in/gr36nX_r Demand Gen Report: https://lnkd.in/gRrEt7h4 MarTech: https://lnkd.in/gGM_VBxE AiThority.Com: https://lnkd.in/gu-wdfn5 BNN Breaking: https://lnkd.in/gy7RcsmM Noah News: https://lnkd.in/gn4_kS6u #b2bmarketing #b2b #b2bsales #b2bleadgeneration #b2bleadgen #marketing #digitalmarketingAudyence Launches Industry's First B2B Programmatic Platform Offering Real-Time Demand for Lead GenerationAudyence Launches Industry's First B2B Programmatic Platform Offering Real-Time Demand for Lead Generation
-
Michael Baker shared thisRead this if you want to know the best question to ask a VC who wants to invest in your companyMichael Baker shared thisIn the latest for Above Board, Michael Baker and I talk about how to evaluate independent board director candidates. We discuss questions such as: Who should I choose between a candidate who has deep industry experience vs. someone who has experience in the process of company building? How can a management team determine how much time an independent candidate will actually put into their role on the board? How do independent board members get compensated? What should founders be thoughtful of around taking money and giving board seats to corporate VC's? Bonus: Mike shares the very uncomfortable question that he think founders should ask potential VC’s. https://lnkd.in/gEa8pp8qEvaluating independent board director candidates and determining compensationEvaluating independent board director candidates and determining compensation
-
Michael Baker shared thisMy good friend Steve Kirsh is looking for a founding CTO to join the health tech movement! https://lnkd.in/eY5nBfANMichael Baker shared thisUnique Opportunity for Senior Software Engineers: Join the Healthcare Revolution! Tech Enthusiasts: Khameleon Group is on the lookout for a hands-on Senior Software Engineer. Imagine being the founding engineer of a groundbreaking healthcare services startup, where your talents could position you to the role of Chief Technology Officer (CTO) as the company evolves. About the Role: As the driving force behind a healthcare services startup, you'll be instrumental in shaping its technological foundation. This is no ordinary gig – it's an opportunity to roll up your sleeves, help scale this startup and leave an indelible mark on the industry. Key Requirements: - Must Have US Citizenship, No Sponsorships available - Proven experience as a Senior Software Engineer - Passion for innovation and a hands-on approach - Previous collaboration with healthcare and interfacing with State Governments is a plus - Vision to contribute to the well-being of individuals with intellectual and physical disabilities What's in it for You: - Competitive salary $180,000-$220,000 that reflects your expertise: - Equity in a game-changing startup - Full benefits package to support your well-being Impact Lives: By joining us, you'll play a pivotal role in improving the lives of people facing intellectual and physical disabilities. It's not just a job – it's a mission. How to Apply: Check out the detailed Job Description (JD) and contact information attached. If you're ready to embark on a journey of innovation and social impact, this is your chance. Be a part of something extraordinary... #SoftwareEngineer #CTO #HealthcareInnovation #TechRevolution #KhameleonGroup #CareerOpportunity #remotework If you know of someone that fits this description, please send them my way. Thanks, Steve
-
Michael Baker liked thisMichael Baker liked thisWe are excited to share that EQLabs has been awarded a $75,000 Innovation Voucher by the Rhode Island Commerce. This funding will support an independent evaluation at The Warren Alpert Medical School of Brown University, in collaboration with the Eric Darling Lab, to assess how our lab AI platform enhances the speed, quality, and reproducibility of scientific research. This is a significant milestone for EQLabs and Rhode Island's expanding life sciences ecosystem. Two aspects make this achievement particularly meaningful: 1. Scientific Rigor: It is essential that AI in science meets the same evidentiary standards as traditional scientific methods. Having Brown University evaluate the impact of our lab AI on researchers aligns with our vision for the advancement of this field. 2. Rhode Island Ecosystem: As a company based at Ocean State Labs by Portal Innovations, partnered with Brown University, supported by RIHub, RI Bio and funded by Slater Technology Fund, we are proud to contribute to establishing Rhode Island as a hub for AI in the life sciences sector. We extend our gratitude to Governor McKee, Secretary Stefan Pryor, Lisa Carnevale, and the Rhode Island Commerce. Congratulations to fellow awardees Elephant Therapeutics, Lilac Biosciences, and Ropeless Systems, Inc. Full announcement from the Governor's office link in comments #AI #research #BioTech #BioPharma #LifeSciences #TidyData #ELN #LIMS #Biotech #DigitalTransformation #FAIRdata #ALCOA
-
Michael Baker liked thisMichael Baker liked thisIn 1968, my dad landed in Wisconsin with $1,000 borrowed from his uncle and a full scholarship to Marquette University for his Masters in Mechanical Engineering. That was the whole plan. Borrow the money. Show up. Figure it out. In 1972, he had an arranged marriage to my mom, and she joined him in Wisconsin — two strangers building a life together in a place neither of them had ever seen. (Pictured below: the day he became a U.S. citizen.) They moved to Iowa for John Deere. My sister and I were born there. And on the side, they started their own business — one I got to watch grow from a front-row seat. That business is the reason I became a founder. Five times over. Today I get to back founders for a living at Eniac Ventures. My wife spends hers fighting for millions of women and girls through Moms First and Girls Who Code. None of that happens without $1,000, a scholarship, and two people willing to bet on a strange land. 250 years in, the American Dream isn't a nostalgia trip. It's still the operating system for people like my parents, and millions of families just like them. Thank you, and happy 250th birthday, America. 🇺🇸❤️
-
Michael Baker liked thisMichael Baker liked thisHere's a sneak peak of Nightsky Camps, a design-forward eco-camp in the rolling hills of San Luis Obispo opening this Fall. Plant Prefab built 45 bathroom pods for the project -- complete with fixtures, finishes, flooring, and tile installed. They were paired on-site with a low-impact canvas-covered living structure and private deck to create a luxury retreat on California's Central Coast. If you're looking for a company offsite, team retreat, or just a weekend celebration, keep it on your radar. https://nightskycamps.com/
-
Michael Baker liked thisMichael Baker liked thisToday, we're flipping the switch on something our customers have been asking for: Audyence and Demandbase are now connected. The hardest part of an account-based lead generation strategy isn't just knowing which accounts to chase. It's also acting on the right account fast, at scale, and without burning budget. Now, joint customers pull their Demandbase-defined segments straight into Audyence and launch targeted CPL campaigns against those exact accounts, fully aligned with their ABM strategy. Demand generation marketers can now go from account identification to lead generation in as little as 24 hours. We're excited to unlock this approach for our mutual customers and the broader community of marketers seeking innovative approaches to reach their goals. This was a team effort on both sides. Huge thanks to the Audyence team who led this initiative: Roland Deal, Danika Schmidt, and Preston Tesvich. And to the Demandbase team for partnering with us to build it and bring it to market: Gabe Rogol, © Al Torres, Vanessa Willett, David Fiori, Kim Tremblay, MBA, Zach George, Christopher Amabile, and Kurt Gellert, MBA. If you run ABM content syndication campaigns and you're tired of the spreadsheet shuffle between targeting and activation, this one's for you. #ABM #DemandGeneration #B2BMarketing
-
Michael Baker liked thisMichael Baker liked thisI'm not a huge soccer fan, but the #WorldCup is special isn't it?! Mostly because the results often defy expectations. Cape Verde?! While of course I am rooting for the US (let's gooo!!!)... My "bandwagon" team is Cape Verde. Tiny island nation (530,000 people) with far less money and a far smaller talent pool than the powerhouses and they've drawn two previous WC winners, Uruguay and Spain. The latter came into the tournament ranked #2 in the world and a favorite to win the whole thing. Cape Verde was ranked #67 btw. Proof that teamwork, planning, discipline and determination count just as much or more than talent, size and money. Impressive so far and I hope they go far! Last week, some of our team members at Audyence hosted B2B marketing execs at #MetLife for the France v. Senegal match (no upset there!). Shout out to Alyssa Baumann and Matthew Knight for hosting, and thank you to the many marketers who attended! And this week, we're heading to #LeviStadium for Australia v. Paraguay. Go Socceroos (because the nickname is too good not to root for)! We'd planned for just these two events as part of our #PitchsideInvitationalSeries, but if the US or Cape Verde go beyond the knockout round, maybe there ought to be a third! 🤔
-
Michael Baker liked thisMichael Baker liked thisIn my first few weeks @ dataxu I was in Michael Baker's office with Sandro Catanzaro and Bill Simmons. Mike, Bill and Sandro were white boarding some product workflow features etc. I walked out feeling completely demoralized by the complexity of AdTech. I honestly understood every 6 words they were saying. Full of self-doubt. But, quickly I got there. Enough to contribute. Enough to give a POV. And then, the real work began. Every Single TechGC has had this journey. If they say they have not, they're lying.
Experience & Education
-
Lakevale Capital
View Michael’s full experience
See their title, tenure and more.
or
Recommendations received
2 people have recommended Michael
Join now to viewOther similar profiles
Explore more posts
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content